Bacteremia por Ralstonia mannitolilytica: primer reporte de caso en Perú

Giancarlo Pérez Lazo; Wilmer Silva Caso; Adriana Morales Moreno; Fernando Soto Febres; Liliana Morales Castillo; Hugo Jove Químper; Juana Del Valle Mendoza; Miguel Angel Aguilar Luis; Ronald Aquino Ortega

doi:10.5867/medwave.2021.04.8200

Bacteremia por Ralstonia mannitolilytica: primer reporte de caso en Perú

Giancarlo Pérez Lazo, Wilmer Silva Caso, Adriana Morales Moreno, Fernando Soto Febres, Liliana Morales Castillo, Hugo Jove Químper, Juana Del Valle Mendoza, Miguel Angel Aguilar Luis, Ronald Aquino Ortega

Facultad de Ciencias de la Salud

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

Resumen

The first report of Ralstonia mannitolilytica bacteremia in Peru is presented. The patient was a pediatric cancer patient with a long-term central venous access device. For the diagnosis, the MicroScan Walk Away 96 automated system was used. 16S rDNA was amplified by conventional PCR, and the bacterial genus and species were identified by genetic sequencing. In addition, the bacterial resistance profile to major antimicrobials was determined. The article discusses the need to actively monitor Ralstonia mannitolilytica, especially in hospital areas of immunocompromised patients.

Título traducido de la contribución	Bacteremia due to Ralstonia mannitolilytica: A report of the first case in Peru
Idioma original	Español
Número de artículo	e8200
Publicación	Medwave
Volumen	21
N.º	4
DOI	https://doi.org/10.5867/medwave.2021.04.8200
Estado	Publicada - may. 2021

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.5867/medwave.2021.04.8200

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{36e196c2e8d948b3aa5fd4143382dd68,

title = "Bacteremia por Ralstonia mannitolilytica: primer reporte de caso en Per{\'u}",

abstract = "The first report of Ralstonia mannitolilytica bacteremia in Peru is presented. The patient was a pediatric cancer patient with a long-term central venous access device. For the diagnosis, the MicroScan Walk Away 96 automated system was used. 16S rDNA was amplified by conventional PCR, and the bacterial genus and species were identified by genetic sequencing. In addition, the bacterial resistance profile to major antimicrobials was determined. The article discusses the need to actively monitor Ralstonia mannitolilytica, especially in hospital areas of immunocompromised patients.",

author = "Lazo, \{Giancarlo P{\'e}rez\} and Caso, \{Wilmer Silva\} and Moreno, \{Adriana Morales\} and Febres, \{Fernando Soto\} and Castillo, \{Liliana Morales\} and Qu{\'i}mper, \{Hugo Jove\} and Mendoza, \{Juana Del Valle\} and Luis, \{Miguel Angel Aguilar\} and Ortega, \{Ronald Aquino\}",

year = "2021",

month = may,

doi = "10.5867/medwave.2021.04.8200",

language = "Espa{\~n}ol",

volume = "21",

journal = "Medwave",

issn = "0717-6384",

publisher = "Medwave Estudios Ltda",

number = "4",

}

TY - JOUR

T1 - Bacteremia por Ralstonia mannitolilytica

T2 - primer reporte de caso en Perú

AU - Lazo, Giancarlo Pérez

AU - Caso, Wilmer Silva

AU - Moreno, Adriana Morales

AU - Febres, Fernando Soto

AU - Castillo, Liliana Morales

AU - Químper, Hugo Jove

AU - Mendoza, Juana Del Valle

AU - Luis, Miguel Angel Aguilar

AU - Ortega, Ronald Aquino

PY - 2021/5

Y1 - 2021/5

N2 - The first report of Ralstonia mannitolilytica bacteremia in Peru is presented. The patient was a pediatric cancer patient with a long-term central venous access device. For the diagnosis, the MicroScan Walk Away 96 automated system was used. 16S rDNA was amplified by conventional PCR, and the bacterial genus and species were identified by genetic sequencing. In addition, the bacterial resistance profile to major antimicrobials was determined. The article discusses the need to actively monitor Ralstonia mannitolilytica, especially in hospital areas of immunocompromised patients.

AB - The first report of Ralstonia mannitolilytica bacteremia in Peru is presented. The patient was a pediatric cancer patient with a long-term central venous access device. For the diagnosis, the MicroScan Walk Away 96 automated system was used. 16S rDNA was amplified by conventional PCR, and the bacterial genus and species were identified by genetic sequencing. In addition, the bacterial resistance profile to major antimicrobials was determined. The article discusses the need to actively monitor Ralstonia mannitolilytica, especially in hospital areas of immunocompromised patients.

UR - https://www.scopus.com/pages/publications/85153077761

U2 - 10.5867/medwave.2021.04.8200

DO - 10.5867/medwave.2021.04.8200

M3 - Artículo

AN - SCOPUS:85153077761

SN - 0717-6384

VL - 21

JO - Medwave

JF - Medwave

IS - 4

M1 - e8200

ER -

Bacteremia por Ralstonia mannitolilytica: primer reporte de caso en Perú

Resumen

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto